Delivery Order SPE2DB22D3501-SPE2DB24FTF90
Award Date 10/20/23
Potential Completion Date 10/23/23
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Capecitabine 500 mg tablets (120 count) with a ceiling value of $1,147.38. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $576 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 120 tablets of 500mg capecitabine. The order was placed under an existing prime vendor contract vehicle to support the agency's pharmaceutical procurement needs. Performance will take place in Conshohocken, Pennsylvania over a period of one day from August 21st to August 22nd, 2023. No subcontractors or set aside designations were indicated. The order continues...
- The Defense Logistics Agency awarded a $1,775.01 delivery order to AmerisourceBergen Drug Corp for Capecitabine 500 mg tablets (120-count) on April 23, 2025, with completion scheduled for April 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing under a delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,647.00 to AmerisourceBergen Drug Corp for the supply of Capecitabine 500 mg tablets (120 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. As a...
- The Defense Logistics Agency Troop Support Medical awarded a $138,270 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 capsules of 150mg Capecitabine tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 15, 2023 through September 18, 2023 to supply this pharmaceutical product in support of DLA Troop Support Medical's mission to provide...
- The Defense Logistics Agency awarded a $980.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 120 tablets of 500mg capecitabine. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by July 25, 2023 to support the agency's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Capecitabine 500 mg tablets in a quantity of 120 units, with a ceiling value of $1,093.68. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025. The contract was not set aside for any particular business category and was competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a $980.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 120 tablets of 500mg capecitabine. The prime contractor will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Capecitabine 500 mg tablets. The contract has a ceiling value of $6,330.32 and an ultimate completion date of October 19, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Capecitabine 500 mg tablets to the Defense Logistics Agency (DLA). The $12,351.20 firm-fixed-price delivery order, awarded on January 30, 2024, has an ultimate completion date of January 31, 2024. The contract is not designated as a set-aside award. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTF90Delivery Order
The Defense Logistics Agency awarded a $3,408.27 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 120 tablets of 500 mg Capecitabine. Performance will occur in Conshohocken, Pennsylvania by October 23, 2023. The delivery order was awarded on October 20, 2023 under an existing vehicle and does not have a set-aside designation. As the DLA supports military treatment facilities, this order for the cancer treatment medication will help ensure availability for eligible beneficiaries.
Generated 1/19/24, 10:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 10/20/23 |